Received Jan 3, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | C9X3R | IM / RA |
Patient presented to the pharmacy for his "2nd" dose of Shingrix on 01/03/2026. Upon reviewing the patient vaccine history I discovered that the patient had already been fully vaccinated with 2 doses of Shingrix on 09/05/2020 and 11/14/2020 and was not recommended to receive the vaccine that was administered on 10/16/2025. After this discovery I consulted with the patient who reported NO adverse events or side effects.